PAVM [NASD]
PAVmed Inc.
Index- P/E- EPS (ttm)-0.73 Insider Own1.20% Shs Outstand86.34M Perf Week-26.90%
Market Cap108.03M Forward P/E- EPS next Y-0.87 Insider Trans0.00% Shs Float78.72M Perf Month19.01%
Income-58.10M PEG- EPS next Q-0.23 Inst Own23.10% Short Float8.33% Perf Quarter45.45%
Sales0.70M P/S154.33 EPS this Y10.40% Inst Trans-1.81% Short Ratio5.07 Perf Half Y-15.79%
Book/sh0.50 P/B2.88 EPS next Y0.00% ROA-88.80% Target Price6.00 Perf Year-76.12%
Cash/sh0.90 P/C1.60 EPS next 5Y- ROE-132.20% 52W Range0.82 - 9.70 Perf YTD-41.46%
Dividend- P/FCF- EPS past 5Y-8.40% ROI-97.50% 52W High-87.06% Beta0.49
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin-38.50% 52W Low53.05% ATR0.24
Employees89 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)42.47 Volatility22.48% 14.55%
OptionableYes Debt/Eq0.02 EPS Q/Q-52.60% Profit Margin- Rel Volume1.30 Prev Close1.44
ShortableYes LT Debt/Eq0.00 EarningsAug 16 AMC Payout- Avg Volume1.30M Price1.25
Recom2.00 SMA20-22.05% SMA500.72% SMA200-33.15% Volume506,795 Change-12.85%
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
Aug-17-22 08:50AM  
Aug-16-22 04:40PM  
Aug-15-22 04:25PM  
Aug-11-22 08:25AM  
Aug-04-22 08:25AM  
Aug-03-22 08:25AM  
Jul-19-22 08:25AM  
Jul-18-22 08:25AM  
May-13-22 08:25AM  
May-12-22 04:38PM  
May-11-22 04:00PM  
May-09-22 08:25AM  
May-04-22 07:03AM  
Apr-28-22 04:05PM  
Apr-26-22 08:25AM  
Apr-25-22 08:25AM  
Apr-04-22 08:25AM  
Mar-30-22 08:25AM  
Mar-29-22 04:11PM  
Mar-24-22 08:25AM  
Mar-23-22 08:25AM  
Mar-17-22 11:39AM  
08:25AM  
Mar-10-22 08:25AM  
Mar-08-22 08:30AM  
Mar-07-22 08:30AM  
Mar-04-22 08:25AM  
Mar-03-22 08:25AM  
Feb-24-22 08:25AM  
Feb-17-22 10:25AM  
Feb-15-22 08:25AM  
Feb-10-22 08:25AM  
Feb-01-22 05:38PM  
Jan-12-22 08:25AM  
Jan-06-22 08:30AM  
Dec-22-21 06:16PM  
Dec-01-21 08:30AM  
Nov-17-21 08:30AM  
Nov-16-21 04:13PM  
Nov-11-21 08:30AM  
Nov-03-21 08:30AM  
Oct-29-21 08:30AM  
Oct-28-21 08:30AM  
Oct-25-21 08:30AM  
Oct-21-21 12:59PM  
Oct-18-21 06:09PM  
05:45PM  
Oct-13-21 10:15PM  
09:28PM  
Oct-07-21 11:41AM  
09:30AM  
Sep-30-21 10:34AM  
Sep-23-21 01:35PM  
12:39PM  
09:30AM  
Sep-21-21 09:30AM  
Sep-07-21 10:04AM  
Aug-13-21 12:16PM  
Aug-12-21 04:14PM  
Aug-10-21 09:30AM  
Aug-05-21 09:30AM  
Aug-03-21 09:30AM  
Aug-02-21 12:31PM  
Jul-28-21 04:42PM  
09:30AM  
Jul-22-21 09:30AM  
Jun-14-21 09:30AM  
05:06AM  
Jun-10-21 09:30AM  
Jun-02-21 09:30AM  
May-26-21 09:30AM  
May-25-21 09:30AM  
May-24-21 09:30AM  
May-17-21 04:00PM  
02:45PM  
May-13-21 09:30AM  
May-06-21 09:30AM  
May-03-21 09:30AM  
Apr-29-21 09:30AM  
Apr-27-21 09:30AM  
Apr-15-21 09:30AM  
Apr-08-21 09:30AM  
Mar-10-21 09:30AM  
Mar-03-21 09:30AM  
Mar-01-21 09:30AM  
Feb-25-21 12:37PM  
Feb-23-21 09:00AM  
07:25AM  
Feb-22-21 04:13PM  
08:18AM  
Feb-18-21 09:30AM  
Feb-16-21 09:30AM  
Feb-11-21 08:30AM  
Feb-09-21 09:30AM  
Jan-08-21 10:53AM  
Jan-06-21 09:29AM  
Dec-22-20 12:04PM  
Dec-18-20 09:29AM  
Dec-16-20 02:53AM  
Dec-11-20 09:29AM  
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAVmed Inc.10% OwnerOct 18Buy14.00571,4287,999,99227,927,190Oct 20 05:04 PM